Nicola Thompson is the founder of Amphista Therapeutics. Amphista Therapeutics has raised $61M in total funding. Latest round: Series B.
Dr. Nicola Thompson is the founding CEO of Amphista Therapeutics, a biopharmaceutical company focused on targeted protein degradation for cancer treatment. She led the company through its Series A and Series B funding rounds and secured significant partnerships with pharmaceutical companies.
Full founder directory · Investor directory · Company funding database · Fundraising library